|
COL1A2 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.9892000015569E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.042900E-04 |
| Normal-vs-Stage2 |
3.850200E-01 |
| Normal-vs-Stage3 |
1.403130E-03 |
| Normal-vs-Stage4 |
1.141060E-03 |
| Stage1-vs-Stage2 |
2.450400E-02 |
| Stage1-vs-Stage3 |
2.028200E-02 |
| Stage1-vs-Stage4 |
7.683200E-03 |
| Stage2-vs-Stage3 |
3.463600E-03 |
| Stage2-vs-Stage4 |
2.063500E-03 |
| Stage3-vs-Stage4 |
3.909200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.45840000041065E-07 |
| Normal-vs-AfricanAmerican |
7.489800E-02 |
| Normal-vs-Asian |
6.342200E-03 |
| Caucasian-vs-AfricanAmerican |
6.509800E-01 |
| Caucasian-vs-Asian |
4.646200E-01 |
| AfricanAmerican-vs-Asian |
4.680800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.363700E-04 |
| Normal-vs-Female |
4.23360000001427E-06 |
| Male-vs-Female |
8.897800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.957800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.202560E-03 |
| Normal-vs-Age(61-80Yrs) |
8.588700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.433850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.605400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.522400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.446600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.218800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.444400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.116400E-02 |
| Classical-VS-Follicular |
5.22740000175048E-08 |
| Classical-VS-Other |
1.972670E-04 |
| Classical-VS-Normal |
5.29379999947288E-07 |
| Tall-VS-Follicular |
1.91619999999615E-05 |
| Tall-VS-Other |
3.67470000000036E-05 |
| Tall-VS-Normal |
3.52279999999983E-05 |
| Follicular-VS-Other |
9.053400E-01 |
| Follicular-VS-Normal |
4.881200E-01 |
| Other-VS-Normal |
8.194800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.075700E-03 |
| Normal-vs-N1 |
2.198700E-03 |
| N0-vs-N1 |
1.492200E-02 |
|
|
